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Iain Mattaj is today one of the
most active and respected
molecular biologists worldwide
but, for such a distinguished
scientist, his career got off to
rather a slow start. He was born in
Scotland of a Polish father and
studied biochemistry at the
University of Edinburgh. He then
moved south of the border to
Leeds to work on a PhD. He was
attracted to a project on offer
there — development of an
antenatal screening technique for
testicular feminization — because
of the potential for applying
molecular biology to the study of
human illness. Unfortunately,
however, the work had to be
abandoned because it proved
impossible to secure sufficient
material for biopsy and Mattaj was
forced to switch track.
He finally managed to clone the
gene encoding glutamate
dehydrogenase in Escherichia coli
and this gave him enough material
to complete his doctorate. He still
seems slightly surprised that his
PhD was awarded. “Nobody had
emphasized that I would have to
produce anything at the end of my
studies so I spent most of my time
reading about completely
unrelated research, which I found
much more interesting than
anything I was able to do.” His
drive to keep up with the
literature, even that not at all
connected with his area, has
remained with him to this day. As
he says, “I no longer have as
much time as I used to but I still
feel that wide reading is essential
for the type of person I am. I have
always been as interested in the
work of others as in my own
research. And new impulses and
ideas can come from the most
unlikely sources.”
Mattaj remained at Leeds for a
further year after completion of his
PhD to characterize the glutamate
dehydrogenase genes further. But
during his PhD work Mattaj had
visited the Friedrich Miescher
Institute (FMI) in Basel to learn
some of the techniques involved
in cloning and DNA analysis and
after he finished his PhD the
leader of the group at the FMI,
Jean-Pierre Jost, offered him a
post-doctoral position. “I had
achieved very little during my PhD
so this was an offer I simply
couldn’t refuse,” he says. In
addition, Jost’s group was
working on hormone-dependent
gene expression in humans, a
topic related to Mattaj’s aborted
PhD attempt and one that he had
continued to follow avidly in the
literature.
He spent a total of three years
at the FMI but left when he failed
to replicate some of the key
results on which his project was
based, which he felt were
probably artefactual. His work
cannot by any standards be
considered as a success and this,
coupled with his lacklustre PhD
work, made him consider
seriously whether he was cut out
for science. He remained
fascinated by research but his
publication record meant that he
was unable to apply for an
independent position. He thus
looked around for a second post-
doctoral position.
While at the FMI, Mattaj had
attended many lectures and
seminars at the nearby Biocentre
of the University of Basel. At that
time, the Biocentre was an
extremely exciting place: Walther
Gehring and Jeff Schatz were
performing work that had brought
them international recognition and
many other group leaders were
also undertaking cutting-edge
research. Among them was Eddy
De Robertis, who had recently
arrived from Cambridge, UK and
whose job seminar Mattaj had
attended. De Robertis was
studying nuclear import and tRNA
processing and Mattaj was
attracted by the idea that a similar
combination of techniques could
be applied to address two such
different biological phenomena.
De Robertis wanted to move
towards the study of nuclear
import of small nuclear RNAs
(snRNAs) and was looking for
someone to work in this area. He
had friends at the FMI who
convinced him that Mattaj showed
potential, so De Robertis hired him
as a senior postdoc/researcher
despite his modest publication
record.
In De Robertis’ lab, Mattaj
concentrated initially on the
cloning and characterization of
UsnRNA genes from Xenopus
laevis. At the same time he
studied the factors involved in
creating and maintaining the
structure of the snRNPs, the
particles in which snRNAs were
found in cells.
Mattaj’s three years under De
Robertis were highly productive
and he was able to secure a
Group Leader position at the
EMBL in Heidelberg, where he
initially continued to work on
UsnRNA gene transcription and
UsnRNP structure. An early
finding was that one of the
Xenopus UsnRNA genes, the one
encoding U6, was transcribed by
RNA polymerase III (pol III) while
all the other known UsnRNA
genes from this organism were
transcribed by pol II. Even more
strangely, U6 appeared
superficially more similar to
classical pol II transcription units
than the other, somewhat
aberrant UsnRNA genes. Mattaj
devoted considerable time and
energy to learning what made the
U6 promoter so different. On
discovering the answer, that a
special, additional TATA-binding
protein complex binds to U6 and
confers pol III specificity, he
decided almost overnight to
cease working on gene
transcription.
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His decision may seem
surprising but Mattaj justifies it
with disarming frankness. “One of
the biggest mistakes I made
earlier was continuing with
projects for too long. I wanted to
cash in on the effort I had spent
establishing experimental
methods but I was not learning
anything new and time was
essentially wasted,” he says.
He had continued to work in
parallel on snRNPs, focussing
especially on the issue of their
nuclear uptake. The technology he
developed — making mutants and
examining whether they still
entered the nucleus — was
applicable to structural studies of
RNPs and over the next few years
his group made several major
contributions to this issue.
Around this time, Riccardo
Cortese left the EMBL to head the
new research institute outside
Rome funded by a consortium
including the Italian government,
Sigma Tau and Merck, Sharp and
Dohme. Cortese had been
Programme Coordinator of the
“Gene Expression” division of the
EMBL, where Mattaj worked.
Mattaj was extremely happy at the
EMBL and was keen to stay
longer than the normal nine-year
maximum for Group Leaders: the
position of Programme
Coordinator came with “rolling
tenure” that would offer him
longer-term security. Because of
the quality and diversity of his
research, he was a natural choice
to succeed Cortese.
Mattaj was still actively
researching but his group was
expanding (he had at that time
about 10 people in his lab, which
later rose to a constant total of
about 14) and he felt that the
additional responsibilities
associated with the position of
Programme Coordinator meant
that he had too little time to
continue to perform experiments
and at the same time supervise all
his students. With reluctance,
then, he finally quit working at the
bench.
His elevation to Programme
Coordinator enabled him to play a
more active part in shaping the
direction of the Gene Expression
Programme but Mattaj was
gradually growing frustrated that
the Programme Coordinators
were not able to be more involved
in determining the overall
scientific planning of the EMBL.
He felt that experience of this kind
would be valuable to him when
the time came for him to leave
EMBL but such matters were
reserved for the Director General,
who was advised and supported
by a Scientific Coordinator, by
tradition the Executive Director of
EMBO (the European Molecular
Biology Organization). At the start
of 1999, however, Frank Gannon
decided that the increased activity
of EMBO meant that his duties as
EMBO Executive Director no
longer left him sufficient time to
work for the EMBL in addition, so
he stepped down as Scientific
Coordinator. Fotis Kafatos, the
Director General of EMBL,
recalled Mattaj’s wish to be more
involved in the overall planning of
EMBL and offered him the
position, which was to be
renamed Scientific Director.
Mattaj gladly accepted and since
May 1999 he has assumed these
responsibilities in addition to
continuing to coordinate the Gene
Expression programme.
The administrative and
representative tasks associated
with the position of EMBL
Scientific Director impose a major
burden on Mattaj’s time. He has
continued to lead his own highly
successful research group whose
part in elucidating the
mechanisms involved in
nucleocytoplasmic transport he
considers a major contribution.
Fotis Kafatos will step down
from his position as EMBL
Director General in May and
Mattaj has been appointed his
successor. He plans to continue
to work towards his and Kafatos’
stated goals — increasing the
importance of systems biology
and strengthening the links
between computational science
and ‘wet’ biology. He thus does
not feel the need to make his
scientific mark on the EMBL by
immediately changing direction.
As he says, “at the moment I don’t
think any changes are required. I
am convinced the move towards
systems analysis is the right one.
The challenge of the position is
rather to ensure that the entire
laboratory – including the four
outstations – continues to perform
absolutely top-quality research
and to be a model for the
interdisciplinary approach to
problems in the life sciences.
“In a distributed organization
there is a real danger that some
people — particularly those in the
outstations — will feel less
involved in decision-making
processes and we should continue
to take steps to ensure that this
does not happen,” he says.
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Paper takes: The next director-general of the European Molecular Biology Laboratory,
Iain Mattaj, attaches great value to reading widely the research of others.
One obvious question is who
will replace him as Scientific
Director when he assumes the
position of Director General.
Mattaj is far from certain that the
position of Scientific Director
should be continued. “It may be
better to try to involve the
scientific staff more broadly in
policy issues — we have a really
good group of senior scientists. It
may be possible to break up the
tasks of the Scientific Director and
share them out among the senior
scientists,” he says. “This
decision needs more thought and
internal discussion.”
Mattaj has been at the EMBL for
nearly twenty years, yet he
continues to feel that staff rotation
is a vital part of the organization’s
policy. “This is a critical aspect of
EMBL, one of the unique things
about the place. People come
here to work for a while and then
bring back the EMBL style — a
commitment to excellence,
flexibility, interdisciplinarity, a
readiness to collaborate and an
international flavour — to their
home countries. The EMBL thus
has a major influence on the
universities and research
institutes in the Member States.”
Mattaj points out that 12 Directors
of Max Planck Institutes in
Germany have passed through the
EMBL and that various successful
newer research institutes in
Europe, such as Vienna’s IMP and
the Max Planck Institute for Cell
Biology in Dresden, are closely
based on EMBL’s structure and
principles.
Mattaj will be EMBL’s fourth
Director General, following in the
footsteps of John Kendrew,
Lennart Philipson and Fotis
Kafatos. The Director General is
generally rotated about every ten
years, so does Mattaj see this as
his final position? “I doubt it:
nobody will be retiring at 65 when
I’m ten years older [he is currently
52]. I’m sure I’ll go on to do
something else but I have no idea
what that will be and it would be
too distracting now to start
thinking about it,” he says. “For
the moment, my only ambition is
to ensure that EMBL continues to
have a large impact on European
research in the life sciences.”
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Sperm dangers
Males have been shown to have
evolved a number of methods to
increase their chances of mating
success and amongst insects
they show as many different
techniques as in other groups of
animals. Apart from mechanical
manipulations such as mate
guarding and mating plugs,
biochemical compounds of male
glands can influence female
fitness, for example by being
toxic for the female, acting as an
anti-aphrodisiac or inducing
oogenesis and increasing
oviposition rates. For example,
the mating plug contains linoleic
acid which acts as an anti-
aphrodisiac and reduces the
female’s willingness to remate.
But a new study by Boris Baer
at Copenhagen University and
Paul Schmid-Hempel at ETH
Zurich, reporting in the
Proceedings of the Royal
Society, series B, published
online, suggests that sperm
itself may influence female
fitness.
The hymenopterans, bees,
wasps and ants, are of particular
interest because of their often
complex social systems. The
bumble bee, Bombus terrestris,
usually mates with a single male
before hibernating and rearing a
colony of offspring the following
year. But researchers believe
that multiple mating would be
beneficial for the females
because of a reduction in
parasitism in genetically
heterogeneous offspring.
But the researchers looked at
something potentially far more
sinister for the bees: that sperm
itself may influence the breeding
outcome of females. The
researchers looked at the direct
effect of sperm by artificially
inseminating females with sperm
from one or more male donors.
In spite of the theoretical
advantage of multiple matings,
the researchers found that
insemination with sperm from
several males led to a reduction
in female hibernation success,
survival and fitness.
The authors are unsure of the
cause of their observations, but
their results are likely to add to
the intrigue and skulduggery
surrounding the mating systems
of social insects. “Harmful male
traits as detected here are not
necessarily expected to evolve
in social insects because males
depend on females for a
successful completion of a
colony cycle and thus have
strong convergent interest with
their mates.”
Sex puzzle: Researchers have found that artificial insemination of female bumble
bees (Bombus terrestris) with sperm from multiple male donors is linked with a
reduction in fitness. (Photograph: Oxford Scientific Films.)
